Cargando…

Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID‐19

BACKGROUND: To explore the association of thrombo‐inflammatory biomarkers with severity in coronavirus disease (COVID‐19), we measured antiphospholipid antibodies (aPL) and calprotectin in sera of COVID‐19 patients. METHODS: Anticardiolipin antibodies (aCL) and anti‐β2‐glycoprotein I antibodies were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Anna, Nahm, Chung Hyun, Lee, Jin‐Soo, Lee, Mi‐Kyeong, Lee, Kyoung‐Ryul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605160/ https://www.ncbi.nlm.nih.gov/pubmed/34608677 http://dx.doi.org/10.1002/jcla.24004

Ejemplares similares

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
por: Silvin, Aymeric, et al.
Publicado: (2020)

Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021)

Combined spinal-epidural anesthesia in a mild thrombocytopenic patient with antiphospholipid antibody syndrome
por: Kim, Gahyun, et al.
Publicado: (2014)

COVID-19 and antiphospholipid antibodies
por: Butt, Ayesha, et al.
Publicado: (2022)

Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome
por: Hong, Yeon Hee, et al.
Publicado: (2018)

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
por: Zhao, Yuan, et al.
Publicado: (2023)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Recurrent Cerebral Artery Dissection Associated with Seronegative Antiphospholipid Antibody Syndrome
por: Kim, Hee Sue, et al.
Publicado: (2022)

Takayasu arteritis and antiphospholipid antibody syndrome in an elderly woman
por: Lee, Hee-Jeong, et al.
Publicado: (2015)

Meta-Analysis: Urinary Calprotectin for Discrimination of Intrinsic and Prerenal Acute Kidney Injury
por: Chen, Jia-Jin, et al.
Publicado: (2019)

Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia
por: Bnina, Amène Ben, et al.
Publicado: (2022)

Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
por: Pyo, Jung Yoon, et al.
Publicado: (2017)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Primary Antiphospholipid Antibody Syndrome: Neuroradiologic Findings in 11 Patients
por: Kim, Jung Hoon, et al.
Publicado: (2000)

Potential Utility of Fecal Calprotectin in Discriminating Colorectal Polyps From Other Major Etiologies in Children Presenting With Isolated Hematochezia
por: Kim, Yu Bin, et al.
Publicado: (2022)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms
por: Yeo, Jina, et al.
Publicado: (2022)

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
por: Jo, Hyeong Ho, et al.
Publicado: (2022)

Serum Calprotectin Is a Potential Marker in Patients with Asthma
por: Lee, Yun-Gi, et al.
Publicado: (2020)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
por: Kim, Su Yeong, et al.
Publicado: (2019)

Serum calprotectin as a novel biomarker for severity of COVID-19 disease
por: Kaya, Tezcan, et al.
Publicado: (2021)

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
por: Norman, Gary L., et al.
Publicado: (2022)

Antiphospholipid Syndrome and Antibodies
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2014)

Chorea Associated with High Titers of Antiphospholipid Antibodies in the Absence of Antiphospholipid Antibody Syndrome
por: Safarpour, Damoun, et al.
Publicado: (2015)

Calprotectin: from biomarker to biological function
por: Jukic, Almina, et al.
Publicado: (2021)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
por: Calcaterra, Ilenia, et al.
Publicado: (2021)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Upregulation of calprotectin in mild IgE-mediated ovalbumin hypersensitivity
por: Zhu, Qingling, et al.
Publicado: (2017)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
por: Hisada, Ryo, et al.
Publicado: (2023)

Amino Acid-Based Formula in Premature Infants with Feeding Intolerance: Comparison of Fecal Calprotectin Level
por: Jang, Hyo-Jeong, et al.
Publicado: (2018)

Retinal Vein Occlusion in Two Patients with Primary Antiphospholipid Syndrome
por: Kim, Jin Kwan, et al.
Publicado: (2001)

302. Using Antiphospholipid Antibody Presence as an Additional Biomarker to Identify COVID-19 Positive Patients with High Risk for Thrombosis
por: Hewlett, Jennifer R, et al.
Publicado: (2021)

Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
por: Fu, Yu, et al.
Publicado: (2017)

P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19
por: Blickstein, D., et al.
Publicado: (2022)

Laboratory Diagnosis of Antiphospholipid Antibodies
por: Samama, M. M., et al.
Publicado: (1997)

Antiphospholipid antibodies: Paradigm in transition
por: Horstman, Lawrence L, et al.
Publicado: (2009)

Testing for antiphospholipid antibodies at autopsy
por: Hudzik, Bartosz, et al.
Publicado: (2014)

Antiphospholipid Antibodies and Systemic Scleroderma
por: Touré, Awa Oumar, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i6ha93nudgeaog9entu1leinlg